BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22682366)

  • 1. Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection.
    Weng L; Du J; Zhou Q; Cheng B; Li J; Zhang D; Ling C
    Mol Cancer; 2012 Jun; 11():39. PubMed ID: 22682366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristic genomics of peripheral blood mononuclear cells of hepatocellular carcinoma patients with liver-kidney yin deficiency syndrome].
    Weng L; Du J; He WT; Ling CQ
    Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):406-15. PubMed ID: 22500714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
    Li Y; Wu D; Wei C; Yang X; Zhou S
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.
    Villanueva A; Hoshida Y; Battiston C; Tovar V; Sia D; Alsinet C; Cornella H; Liberzon A; Kobayashi M; Kumada H; Thung SN; Bruix J; Newell P; April C; Fan JB; Roayaie S; Mazzaferro V; Schwartz ME; Llovet JM
    Gastroenterology; 2011 May; 140(5):1501-12.e2. PubMed ID: 21320499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.
    Zhu HT; Dong QZ; Sheng YY; Wei JW; Wang G; Zhou HJ; Ren N; Jia HL; Ye QH; Qin LX
    PLoS One; 2012; 7(12):e52393. PubMed ID: 23285022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.
    Yi X; Luk JM; Lee NP; Peng J; Leng X; Guan XY; Lau GK; Beretta L; Fan ST
    Mol Cell Proteomics; 2008 Feb; 7(2):315-25. PubMed ID: 17934217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.
    Zhu G; Liao X; Han C; Liu X; Yu L; Qin W; Lu S; Su H; Chen Z; Liu Z; Liang Y; Huang J; Yu T; Yang C; Huang K; Shang L; Ye X; Li L; Qin X; Xiao K; Peng M; Peng T
    Oncol Rep; 2017 Sep; 38(3):1451-1463. PubMed ID: 28714006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-224 Expression and Polymorphism Predict the Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Liver Resection.
    Wu C; Wang X; Zhang J; Tang G; Xu Y; Lu C; Li Y
    Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Free Virus-Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer.
    Li CL; Ho MC; Lin YY; Tzeng ST; Chen YJ; Pai HY; Wang YC; Chen CL; Lee YH; Chen DS; Yeh SH; Chen PJ
    Hepatology; 2020 Dec; 72(6):2063-2076. PubMed ID: 32171027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin B1 acts as a tumor microenvironment-related cancer promoter and prognostic biomarker in hepatocellular carcinoma.
    Hou Y; Wang X; Wang J; Sun X; Liu X; Hu H; Fan W; Zhang X; Wu D
    J Int Med Res; 2021 May; 49(5):3000605211016265. PubMed ID: 34044639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.
    Wang YY; Qi LN; Zhong JH; Qin HG; Ye JZ; Lu SD; Ma L; Xiang BD; Li LQ; You XM
    Sci Rep; 2017 Feb; 7():42199. PubMed ID: 28181486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.
    Liao R; Wu H; Yi Y; Wang JX; Cai XY; He HW; Cheng YF; Zhou J; Fan J; Sun J; Qiu SJ
    J Exp Clin Cancer Res; 2013 Apr; 32(1):22. PubMed ID: 23601182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
    Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
    Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.
    Zhu GQ; Yang Y; Chen EB; Wang B; Xiao K; Shi SM; Zhou ZJ; Zhou SL; Wang Z; Shi YH; Fan J; Zhou J; Liu TS; Dai Z
    J Transl Med; 2019 Jun; 17(1):203. PubMed ID: 31215439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas.
    Hsiao YW; Chiu LT; Chen CH; Shih WL; Lu TP
    Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31434354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.